Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cross-over Study of Coronary Risk Factors With a Polypill
Sponsor: Fundación EPIC
Summary
Open-label, randomized, cross-over study conducted in a single center, applied to patients receiving a polypill with 100 mg of acetyl salicylic acid and different doses of ramipril and atorvastatin for indication of secondary prevention according to clinical practice, with objective of analyzing the level of systolic blood pressure and LDL-cholesterol in the same patient in 2 different periods: one under treatment of 3 months with the polypill and another of 3 months with the components separately.
Official title: Cross-over Analysis of the Control of Coronary Risk Factors and Level of Platelet Inhibition With a Polypill
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
88
Start Date
2022-10-14
Completion Date
2026-04-30
Last Updated
2025-08-05
Healthy Volunteers
No
Conditions
Interventions
Polypill of acetylsalicylic acid, ramipril and atorvastatin
Administration of acetylsalicylic acid, ramipril and atorvastatin in a polypill during 3 months more
Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatin
Patients will be receiving during 3 months more the same components acetylsalicylic acid, ramipril and atorvastatin than with the polypill
Locations (1)
Hospital Universitario de Cabueñes
Gijón, Principality of Asturias, Spain